James Buchanan

3.2k total citations · 2 hit papers
77 papers, 2.0k citations indexed

About

James Buchanan is a scholar working on Genetics, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James Buchanan has authored 77 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 26 papers in Economics and Econometrics and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James Buchanan's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Genomics and Rare Diseases (18 papers) and Genetic factors in colorectal cancer (8 papers). James Buchanan is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Genomics and Rare Diseases (18 papers) and Genetic factors in colorectal cancer (8 papers). James Buchanan collaborates with scholars based in United Kingdom, United States and Canada. James Buchanan's co-authors include Sarah Wordsworth, Jenny C. Taylor, Katharina Schwarze, Anna Schuh, Lucy Abel, Laurence Roope, A. Sarah Walker, Koen B. Pouwels, Christopher Butler and Julie V. Robotham and has published in prestigious journals such as Science, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

James Buchanan

75 papers receiving 1.9k citations

Hit Papers

The challenge of antimicrobial resistance: What economics... 2018 2026 2020 2023 2019 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The challenge of antimicrobial resistance: What economics can contribute
    2019 401 citations Laurence Roope, Richard Smith et al. Science profile →
  2. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
    2018 349 citations Katharina Schwarze, James Buchanan et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Buchanan United Kingdom 22 541 361 321 228 177 77 2.0k
Michael P. Douglas United States 23 698 1.3× 301 0.8× 454 1.4× 439 1.9× 179 1.0× 61 2.0k
Manuel Posada de la Paz Spain 37 854 1.6× 282 0.8× 687 2.1× 160 0.7× 253 1.4× 219 4.1k
Jay Park Canada 24 215 0.4× 331 0.9× 324 1.0× 168 0.7× 122 0.7× 63 2.4k
Anne Ε. Cust Australia 29 345 0.6× 188 0.5× 611 1.9× 201 0.9× 355 2.0× 158 3.8k
Denny John India 21 131 0.2× 198 0.5× 193 0.6× 99 0.4× 332 1.9× 124 1.8k
Jieming Chen China 27 500 0.9× 135 0.4× 955 3.0× 237 1.0× 95 0.5× 100 3.8k
Robert M. Chamberlain United States 31 286 0.5× 95 0.3× 702 2.2× 214 0.9× 136 0.8× 102 3.2k
Roberta Pastorino Italy 24 164 0.3× 104 0.3× 322 1.0× 146 0.6× 46 0.3× 140 2.0k

Countries citing papers authored by James Buchanan

Since Specialization
Citations

This map shows the geographic impact of James Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Buchanan more than expected).

Fields of papers citing papers by James Buchanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Buchanan. The network helps show where James Buchanan may publish in the future.

Co-authorship network of co-authors of James Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of James Buchanan. A scholar is included among the top collaborators of James Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Buchanan. James Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckell, John, Gail Hayward, Mark R. Middleton, et al.. (2025). Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England. British Journal of Cancer. 133(3). 394–403. 1 indexed citations
2.
Weymann, Deirdre, John Buckell, Samantha Pollard, et al.. (2024). Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada. JAMA Network Open. 7(7). e2420842–e2420842. 2 indexed citations
3.
Marshall, Deborah A., James Buchanan, Kurt D. Christensen, et al.. (2024). Paving the path for implementation of clinical genomic sequencing globally: Are we ready?. Health Affairs Scholar. 2(5). qxae053–qxae053. 5 indexed citations
4.
5.
Pollard, Samantha, Deirdre Weymann, Sarah Wordsworth, et al.. (2022). Defining a Core Data Set for the Economic Evaluation of Precision Oncology. Value in Health. 25(8). 1371–1380. 11 indexed citations
6.
Pollard, Samantha, Deirdre Weymann, Jessica L. Dunne, et al.. (2021). Toward the diagnosis of rare childhood genetic diseases: what do parents value most?. European Journal of Human Genetics. 29(10). 1491–1501. 29 indexed citations
7.
Lewis, Celine, James Buchanan, Angus Clarke, et al.. (2021). Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol. SHILAP Revista de lepidopterología. 1. 23–23. 4 indexed citations
8.
Marshall, Deborah A., Dean A. Regier, Sarah Wordsworth, et al.. (2020). Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling. Value in Health. 23(5). 566–573. 32 indexed citations
9.
Koleva‐Kolarova, Rositsa, James Buchanan, Sarah Wordsworth, & Apostolos Tsiachristas. (2020). RE1 Financing and Reimbursement for Personalised Medicine - Are WE There YET?. Value in Health. 23. S756–S756. 1 indexed citations
10.
Roope, Laurence, James Buchanan, Koen B. Pouwels, et al.. (2020). Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey. BMC Medicine. 18(1). 196–196. 11 indexed citations
11.
Roope, Laurence, Richard Smith, Koen B. Pouwels, et al.. (2019). The challenge of antimicrobial resistance: What economics can contribute. Science. 364(6435). 401 indexed citations breakdown →
12.
Schwarze, Katharina, James Buchanan, Jilles M. Fermont, et al.. (2019). The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genetics in Medicine. 22(1). 85–94. 140 indexed citations
13.
Wordsworth, Sarah, Brett Doble, Katherine Payne, et al.. (2018). Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions. Value in Health. 21(9). 1048–1053. 17 indexed citations
14.
Schwarze, Katharina, et al.. (2018). Are whole Exome and whole Genome Sequencing Approaches Cost-Effective? A Systematic Review of the Literature. Value in Health. 21. S100–S100. 8 indexed citations
15.
Hollowell, Jennifer, Yangmei Li, Reem Malouf, & James Buchanan. (2016). Women’s birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature. BMC Pregnancy and Childbirth. 16(1). 213–213. 32 indexed citations
16.
Peters, Jaime, Chris Cooper, & James Buchanan. (2015). Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol. BMJ Open. 5(11). e008465–e008465. 3 indexed citations
17.
Wordsworth, Sarah, Irene Papanicolas, James Buchanan, et al.. (2008). Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories. Journal of Clinical Pathology. 61(3). 373–376. 5 indexed citations
18.
Wordsworth, Sarah, James Buchanan, Irene Papanicolas, et al.. (2008). Molecular testing for somatic mutations in common cancers: the views of UK oncologists. Journal of Clinical Pathology. 61(6). 761–765. 5 indexed citations
19.
Buchanan, James. (1986). Practical management of cancer pain.. PubMed. 15(8). 1030–1, 1034. 3 indexed citations
20.
Brennan, Geoffrey & James Buchanan. (1981). Revenue Implications of Money Creation under Leviathan. American Economic Review. 71(2). 347–351. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael P. Douglas Breakdown of academic impact, for papers by Manuel Posada de la Paz Breakdown of academic impact, for papers by Jay Park Breakdown of academic impact, for papers by Anne Ε. Cust Breakdown of academic impact, for papers by Denny John Breakdown of academic impact, for papers by Jieming Chen Breakdown of academic impact, for papers by Robert M. Chamberlain Breakdown of academic impact, for papers by Roberta Pastorino
Rankless by CCL
2026